5D4 disrupts several molecular pathways, including MYC, that lead to cancer growth
The findings strongly support the potential use of TopBP1 inhibitors as a targeted cancer therapy.
Read More
MYC
Not in sync: single cells and genes show unanticipated response to estrogen
When experimental findings are not compatible with the textbook view, scientists know they have quite a challenge in their hands. Dr. Fabio Stossi, Dr. Michael
Read More